JP5690822B2 - カンジダに対する能動免疫及び受動免疫の標的としてのｈｙｒ１ - Google Patents

カンジダに対する能動免疫及び受動免疫の標的としてのｈｙｒ１ Download PDF

Info

Publication number
JP5690822B2
JP5690822B2 JP2012517920A JP2012517920A JP5690822B2 JP 5690822 B2 JP5690822 B2 JP 5690822B2 JP 2012517920 A JP2012517920 A JP 2012517920A JP 2012517920 A JP2012517920 A JP 2012517920A JP 5690822 B2 JP5690822 B2 JP 5690822B2
Authority
JP
Japan
Prior art keywords
hyr1
candida
candida albicans
pharmaceutical composition
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012517920A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012532114A5 (https=
JP2012532114A (ja
Inventor
ユエ フー
ユエ フー
グアンピンシェン ルオ
グアンピンシェン ルオ
アシュラフ イブラヒム
アシュラフ イブラヒム
ブレッド ジェイ． スペルバーグ
ブレッド ジェイ． スペルバーグ
ジョン イー． ジュニア エドワーズ
ジョン イー． ジュニア エドワーズ
Original Assignee
ロサンゼルス バイオメディカル リサーチ インスティテュート アットハーバー− ユーシーエルエー メディカル センター
ロサンゼルス バイオメディカル リサーチ インスティテュート アット ハーバー− ユーシーエルエー メディカル センター
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ロサンゼルス バイオメディカル リサーチ インスティテュート アットハーバー− ユーシーエルエー メディカル センター, ロサンゼルス バイオメディカル リサーチ インスティテュート アット ハーバー− ユーシーエルエー メディカル センター filed Critical ロサンゼルス バイオメディカル リサーチ インスティテュート アットハーバー− ユーシーエルエー メディカル センター
Publication of JP2012532114A publication Critical patent/JP2012532114A/ja
Publication of JP2012532114A5 publication Critical patent/JP2012532114A5/ja
Application granted granted Critical
Publication of JP5690822B2 publication Critical patent/JP5690822B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/40—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Passenger Equipment (AREA)
JP2012517920A 2009-07-03 2010-07-02 カンジダに対する能動免疫及び受動免疫の標的としてのｈｙｒ１ Active JP5690822B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22300509P 2009-07-03 2009-07-03
US61/223,005 2009-07-03
PCT/US2010/040949 WO2011003085A1 (en) 2009-07-03 2010-07-02 Hyr1 as a target for active and passive immunization against candida

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015018131A Division JP2015120722A (ja) 2009-07-03 2015-02-02 カンジダに対する能動免疫及び受動免疫の標的としてのｈｙｒ１

Publications (3)

Publication Number Publication Date
JP2012532114A JP2012532114A (ja) 2012-12-13
JP2012532114A5 JP2012532114A5 (https=) 2013-08-15
JP5690822B2 true JP5690822B2 (ja) 2015-03-25

Family

ID=43411487

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012517920A Active JP5690822B2 (ja) 2009-07-03 2010-07-02 カンジダに対する能動免疫及び受動免疫の標的としてのｈｙｒ１
JP2015018131A Pending JP2015120722A (ja) 2009-07-03 2015-02-02 カンジダに対する能動免疫及び受動免疫の標的としてのｈｙｒ１

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015018131A Pending JP2015120722A (ja) 2009-07-03 2015-02-02 カンジダに対する能動免疫及び受動免疫の標的としてのｈｙｒ１

Country Status (15)

Country Link
US (2) US8709446B2 (https=)
EP (1) EP2448959B1 (https=)
JP (2) JP5690822B2 (https=)
KR (1) KR20120085234A (https=)
CN (1) CN102574895B (https=)
AU (2) AU2010266114B2 (https=)
BR (1) BR112012000036A2 (https=)
CA (1) CA2766805A1 (https=)
ES (1) ES2606555T3 (https=)
IL (1) IL217261A0 (https=)
MX (1) MX2012000018A (https=)
NZ (1) NZ597442A (https=)
RU (2) RU2559537C2 (https=)
SG (1) SG177456A1 (https=)
WO (1) WO2011003085A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070077256A1 (en) 1999-11-19 2007-04-05 Los Angeles Biomedical Research Institute Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
WO2011003085A1 (en) 2009-07-03 2011-01-06 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Hyr1 as a target for active and passive immunization against candida
GEP201706766B (en) 2011-07-22 2017-10-25 Los Angeles Biomedical Res Center Methods and compositions for vaccinating against staphylococcus aureus
BR112014005773A2 (pt) * 2011-09-14 2019-09-24 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center composições derivadas de hyr1 e métodos of tratamento usando as mesmas
WO2014144024A1 (en) * 2013-03-15 2014-09-18 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Hyr1 compositions and methods for treating fungal and bacterial pathogens
US10130691B2 (en) 2013-03-15 2018-11-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for treating fungal and bacterial pathogens
GB201306588D0 (en) 2013-04-11 2013-05-29 King S College London Peptides and Binding Partners Therefor
EP3426287A4 (en) 2016-03-09 2020-03-11 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Methods and kits for use in preventing and treating vulvovaginal candidiasis
CN113508176A (zh) 2019-02-28 2021-10-15 米尼翁大学 用于控制白色念珠菌感染的反义寡聚物
CN110229221B (zh) * 2019-06-27 2022-04-12 上海交通大学医学院附属仁济医院 一种用于检测侵袭性白色念珠菌病的抗原及其用途
US20220354935A1 (en) * 2021-04-21 2022-11-10 Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center Vaccination against fungal epitopes to prevent inflammatory bowel diseases
WO2025248488A1 (en) * 2024-05-29 2025-12-04 Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center Compositions and methods for preventing and treating healthcare-associated candida auris infections with dual antigen vaccine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031998A1 (en) 1994-05-23 1995-11-30 The Research & Development Institute, Inc. Candida albicans adhesin as a vaccine
US6747137B1 (en) * 1998-02-13 2004-06-08 Genome Therapeutics Corporation Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
US20070077256A1 (en) * 1999-11-19 2007-04-05 Los Angeles Biomedical Research Institute Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
US20060083750A1 (en) * 1999-11-19 2006-04-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis
US6734344B2 (en) * 1999-12-10 2004-05-11 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agrifood Coniothyrium minitans β-(1,3) exoglucanase gene cbeg 1
US7241613B1 (en) * 2002-06-05 2007-07-10 Oscient Pharmaceuticals Corporation Identification of Candida cell surface proteins and their uses
RU2316595C1 (ru) * 2006-06-16 2008-02-10 Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук Способ получения антимикробного пептида ареницина
WO2011003085A1 (en) 2009-07-03 2011-01-06 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Hyr1 as a target for active and passive immunization against candida

Also Published As

Publication number Publication date
KR20120085234A (ko) 2012-07-31
EP2448959B1 (en) 2016-09-07
AU2016244238A1 (en) 2016-10-27
EP2448959A4 (en) 2013-01-02
AU2010266114B2 (en) 2016-07-14
RU2012103502A (ru) 2013-08-10
SG177456A1 (en) 2012-02-28
RU2015122387A (ru) 2015-10-27
US8709446B2 (en) 2014-04-29
MX2012000018A (es) 2012-03-29
NZ597442A (en) 2014-01-31
CN102574895B (zh) 2014-06-11
WO2011003085A1 (en) 2011-01-06
IL217261A0 (en) 2012-02-29
JP2015120722A (ja) 2015-07-02
ES2606555T3 (es) 2017-03-24
BR112012000036A2 (pt) 2018-04-03
RU2015122387A3 (https=) 2019-01-28
RU2559537C2 (ru) 2015-08-10
WO2011003085A9 (en) 2011-07-28
CA2766805A1 (en) 2011-01-06
CN102574895A (zh) 2012-07-11
JP2012532114A (ja) 2012-12-13
US20140335114A1 (en) 2014-11-13
EP2448959A1 (en) 2012-05-09
AU2010266114A1 (en) 2012-02-02
US20120237534A1 (en) 2012-09-20

Similar Documents

Publication Publication Date Title
JP5690822B2 (ja) カンジダに対する能動免疫及び受動免疫の標的としてのｈｙｒ１
US20120014995A1 (en) Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
US10160790B2 (en) HYR1-derived compositions and methods of treatment using same
US20100285024A1 (en) Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
AU2006244401B2 (en) Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
AU2013203750A1 (en) Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
AU2012216520A1 (en) Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130627

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130627

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140724

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141021

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20141217

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150115

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150202

R150 Certificate of patent or registration of utility model

Ref document number: 5690822

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250